EHA 2016: SGN-CD33A with hypomethylating therapy produces high remission rates among older AML patients - 101793

Spotlight
Video

EHA 2016: SGN-CD33A with hypomethylating therapy produces high remission rates among older AML patients

VJHemOnc has 1073 videos Subscribe Here

Loading........
Description: Press brief by Amir Fathi, MD of the Massachusetts General Hospital, Boston, MA, on SGN-CD33A combined with hypomethylating therapy, which produces high remission rates among older patients with AML at the 2016 Annual Meeting of the European Association of Hematology (EHA), held in Copenhagen, Denmark.
Shared By : VJHemOnc
Posted on : 06/30/16
Added : 2 years ago